Overview
CRBU market data
Price History
No market bars yet for CRBU. This page will populate once the next provider sweep lands.
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for CRBU. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual ConferenceGlobenewswire Inc · Jun 29, 2026, 12:15 PM
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual MeetingGlobenewswire Inc · Jun 11, 2026, 12:15 PM
Caribou Biosciences Reports Longer Follow Up Data For Ongoing CaMMouflage Phase 1 Trial Of CB-011, Off-The-Shelf BCMA-Targeted CAR-T Cell Therapy, Being Evaluated For r/r MMBenzinga · Jun 11, 2026, 12:02 PM
8-K filing — Caribou Biosciences, Inc. (CRBU)SEC EDGAR · Jun 11, 2026, 12:02 PM
HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Raises Price Target to $11Benzinga · May 11, 2026, 11:32 AM